Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: Evidence of a significant relationship

Bone Marrow Transplantation

Volumn 26, Issue 1, 2000, Pages 77-81

  Takemoto, Y ^a   Takatsuka, H ^a   Wada, H ^a   Mori, A ^a   Saheki, K ^a   Okada, M ^a   Tamura, S ^a   Fujimori, Y ^a   Okamoto, T ^a   Kakishita, E ^a   Kanamaru, A ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BMT; Bronchoalveolar lavage fluids; CMV; GVHD; HHV 6

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN HERPESVIRUS 6; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0033924375     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702459     Document Type: Article

References (18)

1. Stocchi R, Szydlo R, Craddock C et al. A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation. Bone Marrow Transplant 1999; 23: 705-709.
2. Wilborn F, Brinkmann V, Schmidt CA et al. Herpesvirus type 6 in patients undergoing bone marrow transplantations: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052-3058.
3. Wang FZ, Dahl H, Linde A et al. Lymphotropic herpes viruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615-3620.
4. Przepiorka D, Smith TL, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465-1470.
5. Maltazou H, Whimbey E, Abi-Said D et al. CMV disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study. Bone Marrow Transplant 1999; 24: 665-669.
6. Miller W, Flynn P, McCullough J et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986; 67: 1162-1167.
7. Takemoto Y, Hashimoto T, Eizuru Y et al. Rapid diagnosis of cytomegalovirus interstitial pneumonitis by the polymerase chain reaction method - comparison of four diagnostic procedures. Kansenshogaku Zasshi 1993; 67: 295-298.
8. Petersen FB, Buckner CD, Appelbaum FR et al. Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase 1 study. Bone Marrow Transplant 1989; 4: 617-623.
9. Schmidt GM, Horak DA, Niland JC et al. A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. The City of Hope-Stanford-Syntex. New Engl J Med 1991; 324: 1005-1011.
10. Singhal S, Metha J, Powles R et al. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 777-781.
11. Yalcin S, Karpuzoglu T, Suleymanlar G et al. Human herpes virus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol 1994; 136: 183-190.
12. Maeda Y, Teshima T, Yamada M et al. Monitoring of human herpes virus after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Br J Haematol 1999; 105: 295-302.
13. Appleton AL, Sviland L, Peiris JSM et al. Role of target organ infection with cytomegalovirus in the pathogenesis of graft -versus-host disease. Bone Marrow Transplant 1995; 15: 557-561.
14. Fajac A, Stephan F, Ibraham A et al. Value of cytomegalovirus detection by PCR in bronchoalveolar lavage routinely performed in asymptomatic bone marrow recipients. Bone Marrow Transplant 1997; 20: 581-585.
15. Sakuma H,Hosoya M, Kanno H et al. Risk of cytomegalovirus infection after peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 49-53.
16. Reddy V, Hao Y, Lipton J et al. Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged preemptive ganciclovir therapy. J Clin Virol 1999; 13: 149-159.
17. Weiner RS, Bortin MM, Gale RP et al. Interstitial pneumonitis after bone marrow transplantation. Ann Intern Med 1986; 104: 168-175.
18. Via CS, Shanley JD, Weatherly BR et al. Altered threshold for the induction of graft-versus-host immunodeficiency following murine cytomegalovirus infection. Host and donor contributions. Transplantation 1988; 46: 298-302.